Corbus Pharmaceuticals Holdings, Inc. Share Price
CRBPCorbus Pharmaceuticals Holdings, Inc. Stock Performance
Open $7.66 | Prev. Close $7.45 | Circuit Range N/A |
Day Range $7.55 - $7.71 | Year Range $4.68 - $19.84 | Volume 3,571 |
Average Traded $7.68 |
Corbus Pharmaceuticals Holdings, Inc. Share Price Chart
About Corbus Pharmaceuticals Holdings, Inc.
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Corbus Pharmaceuticals Holdings, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $7.90 | $7.98 | -1.16% |
03-Feb-26 | $8.35 | $8.07 | -2.25% |
02-Feb-26 | $8.33 | $8.26 | +0.06% |
30-Jan-26 | $8.26 | $8.26 | -4.57% |
29-Jan-26 | $8.37 | $8.65 | -0.12% |
28-Jan-26 | $8.88 | $8.66 | -8.84% |
27-Jan-26 | $9.26 | $9.50 | +2.43% |
FAQs on Corbus Pharmaceuticals Holdings, Inc. Share Price
Can I buy Corbus Pharmaceuticals Holdings, Inc. shares in India?
What is the share price of Corbus Pharmaceuticals Holdings, Inc.?
What is the 5 year returns of Corbus Pharmaceuticals Holdings, Inc.?
What are the high & low stock price of Corbus Pharmaceuticals Holdings, Inc. today?
What is the 52-week high and low of Corbus Pharmaceuticals Holdings, Inc. stock?